EP2411031A4 - Methods and compositions for the treatment of cancer - Google Patents

Methods and compositions for the treatment of cancer

Info

Publication number
EP2411031A4
EP2411031A4 EP10756546A EP10756546A EP2411031A4 EP 2411031 A4 EP2411031 A4 EP 2411031A4 EP 10756546 A EP10756546 A EP 10756546A EP 10756546 A EP10756546 A EP 10756546A EP 2411031 A4 EP2411031 A4 EP 2411031A4
Authority
EP
European Patent Office
Prior art keywords
cancer
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10756546A
Other languages
German (de)
French (fr)
Other versions
EP2411031A2 (en
Inventor
Isaac Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionovo Inc
Original Assignee
Bionovo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/553,878 external-priority patent/US20100069480A1/en
Application filed by Bionovo Inc filed Critical Bionovo Inc
Publication of EP2411031A2 publication Critical patent/EP2411031A2/en
Publication of EP2411031A4 publication Critical patent/EP2411031A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
EP10756546A 2009-03-24 2010-03-01 Methods and compositions for the treatment of cancer Withdrawn EP2411031A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16298809P 2009-03-24 2009-03-24
US17263909P 2009-04-24 2009-04-24
US12/553,878 US20100069480A1 (en) 2008-09-03 2009-09-03 Methods and compositions for the treatment of cancer
PCT/US2010/025801 WO2010110993A2 (en) 2009-03-24 2010-03-01 Methods and compositions for the treatment of cancer

Publications (2)

Publication Number Publication Date
EP2411031A2 EP2411031A2 (en) 2012-02-01
EP2411031A4 true EP2411031A4 (en) 2012-08-01

Family

ID=42781750

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10756546A Withdrawn EP2411031A4 (en) 2009-03-24 2010-03-01 Methods and compositions for the treatment of cancer

Country Status (5)

Country Link
EP (1) EP2411031A4 (en)
JP (1) JP2012521424A (en)
AU (1) AU2010229167A1 (en)
CA (1) CA2756452A1 (en)
WO (1) WO2010110993A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599237B (en) * 2013-11-28 2015-06-03 姜永华 Traditional Chinese medicine for treating gastric cancer of stasis in stomach collateral type and preparation method thereof
EP3476227A4 (en) * 2016-06-24 2020-02-05 Suntory Holdings Limited Composition for browning inhibition and use of same
CN110346494B (en) * 2019-06-03 2021-09-28 云南农业大学 Method for simultaneously measuring contents of 4 effective components in erigeron breviscapus
CN113018347B (en) * 2021-03-01 2022-07-22 中国药科大学 Traditional Chinese medicine extract nanoparticle and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010028187A2 (en) * 2008-09-03 2010-03-11 Bionovo, Inc. Methods and compositions for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0500739B1 (en) * 1989-11-03 1997-03-26 SUN, Alexander S. Herbal treatment of malignancy
US6294526B1 (en) * 1998-02-06 2001-09-25 Alps Pharmaceutical Ind. Co., Ltd. Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010028187A2 (en) * 2008-09-03 2010-03-11 Bionovo, Inc. Methods and compositions for the treatment of cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HOPE RUGO ET AL: "Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer", BREAST CANCER RESEARCH AND TREATMENT, SPRINGER, NEW YORK, NY, vol. 105, no. 1, 1 September 2007 (2007-09-01), USA, pages 17 - 28, XP002620818, ISSN: 0167-6806, DOI: 10.1007/S10549-006-9430-6 *

Also Published As

Publication number Publication date
EP2411031A2 (en) 2012-02-01
WO2010110993A2 (en) 2010-09-30
WO2010110993A3 (en) 2011-01-13
AU2010229167A1 (en) 2011-10-20
CA2756452A1 (en) 2010-09-30
JP2012521424A (en) 2012-09-13

Similar Documents

Publication Publication Date Title
IL258794B (en) Methods and compositions for diagnosis and treatment of cancer
IL225471A0 (en) Compositions and methods for the prevention and treatment of cancer
HK1159498A1 (en) Methods and compositions for the treatment of cancer
IL218987A0 (en) Methods and compositions for treating cancer
ZA201105472B (en) Methods and compositions for diagnosis and treatment of cancer
EP2340027A4 (en) Methods and compositions for the treatment of cancer
IL251083B (en) Compounds and compositions for the treatment of cancer
HK1166305A1 (en) Compositions and methods for the treatment of inflammation
EP2480687A4 (en) Methods and compositions for the diagnosis and treatment of thyroid cancer
EP2558085A4 (en) Compositions and methods for the prevention and treatment of cancer
EP2419136A4 (en) Compositions and methods for treating cancer
IL214349A0 (en) Compositions and methods for the treatment of cancer
IL240560A0 (en) Compositions and methods for the diagnosis and treatment of tumor
EP2437738A4 (en) Methods and compositions for the treatment of cancer
EP2150270A4 (en) Methods and compositions for the treatment of cancer
EP2635273A4 (en) Isoflavonoid compositions and methods for the treatment of cancer
EP2411031A4 (en) Methods and compositions for the treatment of cancer
EP2547368A4 (en) Methods and compositions for the treatment of cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20111021

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120703

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/534 20060101AFI20120627BHEP

Ipc: A61P 35/00 20060101ALI20120627BHEP

Ipc: A61K 31/352 20060101ALI20120627BHEP

Ipc: A61K 31/37 20060101ALI20120627BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130131